Ken Fisher acquired 13.6 Thousand Sarepta Therapeutics shares worth $1.57 Million. That's 0.00% of their equity portfolio (622nd largest holding). The first Sarepta Therapeutics trade was made in Q3 2017. Since then Ken Fisher bought shares eleven more times and sold shares on thirteen occasions. The stake costed the investor $938 Thousand, netting the investor a gain of 68% so far.